Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Paclitaxel

These articles are all highly relevant Paclitaxel. I believe this information can help you understand Paclitaxel's professional information. If you want to know more, you can contact us at any time, we can provide you with more professional guidance.
  • Drug Patent & Exclusivity Expiration Report - Week of Oct 21 2024

    Drug Patent & Exclusivity Expiration Report - Week of Oct 21 2024

    2024-10-22

    This week, there are 3 drugs in the patent and exclusivity list. They are: - BRISTOL-MYERS SQUIBB CO's ABRAXANE, containing active ingredient PACLITAXEL - VERTEX PHARMACEUTICALS INC's TRIKAFTA (COPACKAGED), containing active ingredient ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR - BAUSCH AND LOMB INC's XIPERE, containing active ingredient TRIAMCINOLONE ACETONIDE Read More